(Q36452468)

14 August 2017

1 reference

title

Antioxidants, supplements, and Parkinson's disease (English)

1 reference

14 August 2017

Cynthia A Weber

1

1 reference

PubMed ID

16622156

14 August 2017

Michael E Ernst

series ordinal

2

1 reference

PubMed ID

16622156

14 August 2017

language of work or name

English

0 references

publication date

18 April 2006

1 reference

Annals of Pharmacotherapy

14 August 2017

1 reference

14 August 2017

40

1 reference

14 August 2017

5

1 reference

14 August 2017

935-938

1 reference

Neuroprotection for Parkinson's disease: prospects and promises

14 August 2017

1 reference

Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.

21 January 2018

1 reference

Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions

21 January 2018

1 reference

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

21 January 2018

1 reference

Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk.

21 January 2018

1 reference

Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis

21 January 2018

1 reference

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

21 January 2018

1 reference

Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease

21 January 2018

1 reference

Q10 therapy in patients with idiopathic Parkinson's disease.

21 January 2018

1 reference

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

21 January 2018

1 reference

Reduced intravenous glutathione in the treatment of early Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1G551

1 reference

14 August 2017

1 reference

PubMed ID

16622156